Health in Algeria

1,233 indicators covering health for Algeria.

IndicatorLatest Year10-yr change Rank
Reported number of children receiving antiretroviral therapy 437 2013 β€” 57th
Concentrations of fine particulate matter 19.7 2023 up 12.7% 83rd
Death rate road traffic injuries 20.9 2019 down 6.3% 65th
New or unknown treatment history cases: Pulmonary, bacteriologically 4,635 2023 down 38.1% 69th
Cholera case fatality rate 0 2006 down 100.0% 37th
Medical doctors not further defined 83,713 2020 up 104.9% 15th
Constant stillbirth rate 8.81 2030 unchanged 91st
ENAP target met stillbirth rate 7.11 2030 down 16.8% 95th
Stillbirth rate high-income country 2.8 2030 down 62.6% 1st
Stillbirths remain constant projection 6,857 2030 down 12.5% 48th
Stillbirth maintained projection 5,525 2030 down 27.3% 48th
Stillbirth ENAP 2030 target met projection 5,525 2030 down 27.3% 44th
Stillbirth high-income country average rate matched projection 2,167 2030 down 67.4% 38th
Stillbirth rate current trends 7.11 2030 down 16.8% 95th
Life satisfaction vs life expectancy 76.26 2023 up 1.9% 102nd
Estimate of current cigarette smoking prevalence 15.7% 2030 up 4.0% 64th
Estimate of current cigarette smoking prevalence (%) 15.6% 2030 up 6.1% 64th
Number of children aged 6-59 months with anaemia 1,723 2019 up 33.9% 33rd
Prevalence of anaemia in children aged 6-59 months 34.3% 2019 down 2.6% 73rd
Number of deaths attributed to non-communicable diseases, by type of 30,349 2019 up 39.5% 42nd
Hepatitis B surface antigen (HBsAg) prevalence 0.1% 2024 unchanged 101st
Mean hemoglobin level of children aged 6-59 months 114 2019 unchanged 118th
Estimated number of MDR/RR-TB incident cases 490 2024 down 9.3% 55th
Neonatal mortality rate - Remains constant 14.96 2030 unchanged 61st
Neonatal mortality rate - Current trends maintained 14.82 2030 down 0.8% 55th
Neonatal mortality rate - High-income country average rate matched 2.8 2030 down 75.3% 1st
Neonatal mortality rate - SDG target met 12 2030 down 16.8% 1st
Under 5 mortality rate - Remains constant 21.64 2030 unchanged 70th
Under 5 mortality rate - Current trends maintained 20.02 2030 down 6.2% 66th
Under 5 mortality rate - High-income country average rate matched 5.09 2030 down 69.9% 1st
Under 5 mortality rate - SDG target met 17.21 2030 down 17.4% 75th
Mortality rate age 10-19 - Remains constant 4.35 2030 up 3.8% 111th
Mortality rate age 10-19 - Current trends maintained 3.91 2030 down 5.0% 113th
Mortality rate age 10-19 - High-income country average rate matched 2.56 2030 down 32.0% 132nd
Neonatal deaths - Remains constant 11,550 2030 down 9.8% 41st
Neonatal deaths - Current trends maintained 11,440 2030 down 10.5% 40th
Neonatal deaths - SDG target met 9,263 2030 down 25.0% 34th
Under-five deaths - Remains constant 16,836 2030 down 10.8% 46th
Under-five deaths - Current trends maintained 15,567 2030 down 16.4% 45th
Under-five deaths - SDG target met 13,398 2030 down 26.3% 37th
Deaths age 10 to 19 - Remains constant 3,987 2030 up 15.0% 50th
Deaths age 10 to 19 - Current trends maintained 3,711 2030 up 8.4% 49th
Mortality caused by road traffic injury 20.9 per 100,000 population 2019 down 7.1% 66th
Mortality caused by road traffic injury, female 13.6 per 100,000 female population 2019 down 4.9% 42nd
Mortality caused by road traffic injury, male 28.1 per 100,000 male population 2019 down 7.9% 76th
Countries with birth registration data that are at least 90 percent 1 2024 unchanged 2nd
Ipv vaccine coverage 98 2024 up 1,125.0% 32nd
Number of births in thousands 855.43 2025 down 17.2% 9th
Deaths in armed conflicts by country, annual growth rate -100 % change on previous year 2021 down 794.1% 33rd
Deaths in armed conflicts by region, annual growth rate -100 % change on previous year 2021 down 794.1% 33rd
Hospital beds 16.11 2017 down 6.0% 103rd
New leprosy case detection rate per 1 000 000 population 0 2024 β€” 124th
Prevalence of wasting, weight for height 2.7% 2019 down 34.1% 69th
Earthquake deaths 6 2014 down 99.7% 18th
Sex ratio at birth 1.05 2024 unchanged 68th
Crude birth rate 18.84 2024 down 27.7% 14th
Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 94.0% 2025 β€” 59th
International Health Regulations core capacity scores, SPAR version 70 2025 β€” 49th
Prevalence of underweight, weight for age 2.7% 2019 down 20.6% 80th
Leprosy registered prevalence rate per 1 000 000 population 0 2024 β€” 121st